Gilead Sciences, Inc. (GILD)
144.74
-2.76
(-1.87%)
USD |
NASDAQ |
Oct 02, 16:00
144.92
+0.18
(+0.12%)
After-Hours: 20:00
Gilead Sciences Max Drawdown (5Y) : 26.58% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 26.58% |
| August 31, 2026 | 26.58% |
| July 31, 2026 | 26.58% |
| June 30, 2026 | 26.58% |
| May 31, 2026 | 26.58% |
| April 30, 2026 | 26.58% |
| March 31, 2026 | 26.58% |
| February 28, 2026 | 28.82% |
| January 31, 2026 | 29.81% |
| December 31, 2025 | 31.41% |
| November 30, 2025 | 35.24% |
| October 31, 2025 | 37.27% |
| September 30, 2025 | 38.10% |
| August 31, 2025 | 38.10% |
| July 31, 2025 | 38.10% |
| June 30, 2025 | 38.10% |
| May 31, 2025 | 38.10% |
| April 30, 2025 | 38.10% |
| March 31, 2025 | 38.10% |
| February 28, 2025 | 38.10% |
| January 31, 2025 | 38.70% |
| December 31, 2024 | 41.71% |
| November 30, 2024 | 41.71% |
| October 31, 2024 | 41.71% |
| September 30, 2024 | 43.12% |
| Date | Value |
|---|---|
| August 31, 2024 | 43.18% |
| July 31, 2024 | 43.18% |
| June 30, 2024 | 43.18% |
| May 31, 2024 | 43.18% |
| April 30, 2024 | 43.67% |
| March 31, 2024 | 44.02% |
| February 29, 2024 | 44.02% |
| January 31, 2024 | 44.02% |
| December 31, 2023 | 44.02% |
| November 30, 2023 | 45.75% |
| October 31, 2023 | 45.75% |
| September 30, 2023 | 45.75% |
| August 31, 2023 | 45.75% |
| July 31, 2023 | 45.75% |
| June 30, 2023 | 45.75% |
| May 31, 2023 | 45.75% |
| April 30, 2023 | 45.75% |
| March 31, 2023 | 45.75% |
| February 28, 2023 | 45.75% |
| January 31, 2023 | 45.75% |
| December 31, 2022 | 45.75% |
| November 30, 2022 | 45.75% |
| October 31, 2022 | 45.75% |
| September 30, 2022 | 45.75% |
| August 31, 2022 | 45.75% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| AbbVie, Inc. | 21.89% |
| Regeneron Pharmaceuticals, Inc. | 59.69% |
| Vertex Pharmaceuticals, Inc. | 41.60% |
| Amgen, Inc. | 24.86% |
| Biogen, Inc. | 72.66% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 13.63 |
| Beta (5Y) | 0.3152 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 24.90% |
| Historical Sharpe Ratio (5Y) | 0.6741 |
| Historical Sortino (5Y) | 1.452 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 8.07% |